Answers are grounded in this paper and cite their sources.
The addition of the neuropeptide carnosine (beta-alanyl-L-histidine) as a food additive to the basic protocol of Parkinson's disease treatment results in significant improvement of neurological symptoms, along with increase in red blood cell Cu/Zn-SOD and decrease in blood plasma protein carbonyls and lipid hydroperoxides, with no noticeable change in platelets MAO B activity. The combination of carnosine with basic therapy may be a useful way to increase efficiency of PD treatment.
No takes yet. Share an insight, caveat, or question.
Болдырев et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: